.
Rev Environ Health. 2017 Sep 26;32(3):235-244. doi: 10.1515/reveh-2016-0059.
This paper is primarily aimed to review articles on electronic cigarettes (e-cigarettes) focusing on indoor air quality (IAQ) assessment that were conducted using human volunteers under natural settings that mimic actual vaping scenarios. Such studies may give a better representation of the actual potential exposure towards e-cigarettes emissions in indoor settings.
A systematic literature search was conducted using PubMed search engine database. Search terms such as "electronic cigarette", "e-cigarette", "electronic nicotine delivery system", and "indoor air quality" were used to identify the relevant articles to be included in this review. Articles that involved human volunteers who were asked to vape in natural settings or settings that mimic the actual vaping scenario were chosen to be reviewed. The search yielded a total of 15 published articles. Eleven articles were excluded due to 1) unavailability of its full-text (n=1), 2) did not involve human volunteers (n=5) and 3) did not involve an IAQ study (n=5). Four articles were critically reviewed in this paper.
From the four selected articles, two of the papers focused on the determination of nicotine level released by e-cigarettes whereas the other two covered IAQ parameters namely; particulate matters (PM), propylene glycols, formaldehyde, metals and polycyclic aromatic hydrocarbons (PAHs). Only two of the studies involved determination of biomarkers of exposure. The level of chemical contents released varied between studies. The differences in the brands of e-cigarette used, number of vapers recruited and the sensitivity of the methodologies employed in these studies may be the possible causes for such differences. However, studies using human volunteers conducted in a natural setting are more relevant to portray the actual exposure to vapors among e-cigarettes users and non-users compared to studies using a smoking machine/an exposure chamber. This is because such studies take into account the behavior of consumers and individual retention of nicotine. Such method will therefore avoid the possibility of overestimation in terms of exposures toward e-cigarettes users and non-users.
There are limited e-cigarette studies on the impact of IAQ performed using human volunteers in natural settings. The available studies however, provided inconsistent scientific evidence on the actual exposure towards the vapor contents as unstandardized methodology were used in conducting such research. Therefore, there is a need to conduct IAQ studies in natural settings by using a standardized protocol in terms of the number of vapers recruited, the size of the indoor settings, the methods used in detecting and quantifying the contents and levels of emissions and the sensitivity of the equipment used in analyzing the contents. This will help in better utilization of the findings from such studies for the use of risk assessment of the exposures towards e-cigarette emissions. There is also a need to emphasize that it is the onus of the manufacturers in providing and proving scientifically sound safety claims for their products prior to commercializing it in the market.
本文主要综述了在自然环境下使用人体志愿者模拟实际电子烟使用场景进行的电子烟(e-cigarette)室内空气质量(IAQ)评估相关研究。此类研究可以更好地反映室内环境中电子烟排放物的实际潜在暴露情况。
使用 PubMed 搜索引擎数据库进行系统文献检索。使用了“电子香烟”、“电子烟”、“电子尼古丁输送系统”和“室内空气质量”等搜索词,以确定纳入本综述的相关文章。选择涉及要求志愿者在自然环境或模拟实际电子烟使用场景的环境中吸入电子烟的人体志愿者的文章进行综述。该搜索共产生了 15 篇已发表的文章。由于 1)无法获取全文(n=1),2)不涉及人体志愿者(n=5),3)不涉及室内空气质量研究(n=5),11 篇文章被排除在外。本文对其中的 4 篇文章进行了批判性回顾。
从 4 篇选定的文章中,有 2 篇重点研究了电子烟释放的尼古丁水平,另外 2 篇涵盖了室内空气质量参数,即:颗粒物(PM)、丙二醇、甲醛、金属和多环芳烃(PAHs)。只有 2 项研究涉及暴露生物标志物的测定。研究之间释放的化学物质含量存在差异。这种差异可能是由于电子烟使用的品牌不同、招募的吸烟者人数不同以及研究中使用的方法的灵敏度不同所致。然而,在自然环境中使用人体志愿者进行的研究比使用吸烟机/暴露室进行的研究更能真实地描绘电子烟使用者和非使用者的实际蒸气暴露情况。这是因为此类研究考虑了消费者的行为和尼古丁的个体保留。因此,这种方法可以避免对电子烟使用者和非使用者的暴露情况进行过高估计。
在自然环境中使用人体志愿者进行的室内空气质量影响的电子烟研究有限。然而,现有的研究提供了不一致的科学证据,证明实际暴露于蒸气含量,因为在进行此类研究时使用了非标准化的方法。因此,需要在自然环境中使用标准化协议进行室内空气质量研究,包括招募的吸烟者人数、室内环境的大小、用于检测和量化排放物含量和水平的方法以及用于分析含量的设备的灵敏度。这将有助于更好地利用此类研究的结果,用于电子烟排放物暴露风险评估。此外,还需要强调的是,制造商有责任在将产品推向市场之前提供并证明其产品具有合理的科学安全性。